Background A disintegrin and metalloprotease 9 (ADAM9) is a membrane-anchored enzyme which is considered to be involved in some diseases including tumor. However, the role of ADAM9 in castration resistant prostate cancer (CRPC) is not clear. This study aimed to explore the different expressions on protein and messenger RNA (mRNA) level of ADAM9 between hormonal sensitive prostate cancer (HSPC) and CRPC tissue, and find the correlation with prognosis.
LIN Guo-wenYAO Xu-dongYE Ding-weiZHANG Shi-linDAI BoZHANG Hai-liangMA Chun-guang
耻骨后根治性前列腺切除术(radical prostatectomy,RP)技术不断改进,不仅能彻底控制肿瘤,而且能达到满意的术后功能保留.对于局限性前列腺癌,RP是理想的初始治疗.2002年7月至2010年9月,我院收治了25例经尿道前列腺电切(transurethral resection of the prostate,TURP)发现的临床局限性前列腺癌患者,其中21例接受过内分泌治疗,均行RP,疗效满意,现报告如下.